MENU

ENTX Entera Bio Ltd Forecast, Technical & Fundamental Analysis

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

ENTX is expected to report earnings to fall 1.43% to -13 cents per share on March 26

Entera Bio Ltd ENTX Stock Earnings Reports
Q4'26
Est.
$-0.14
Q2'26
Missed
by $0.05
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.05
Q3'25
Beat
by $0.16
The last earnings report on August 10 showed earnings per share of -14 cents, missing the estimate of -9 cents. With 68.11K shares outstanding, the current market capitalization sits at 543.67M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXL1.470.07
+5.00%
Nexalin Technology Inc.
BHVN14.480.58
+4.17%
Biohaven Ltd
CMDB18.480.69
+3.88%
Costamare Bulkers Holdings Ltd
LFVN5.220.17
+3.37%
Lifevantage Corp
HMY17.170.27
+1.60%
Harmony Gold Mining Company Limited

ENTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ENTX and JSPR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTX and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
+5.02%
JSPR - ENTX
32%
Poorly correlated
+19.78%
MLTX - ENTX
30%
Poorly correlated
+6.76%
QCLS - ENTX
26%
Poorly correlated
+2.69%
NTLA - ENTX
26%
Poorly correlated
+2.25%
LGVN - ENTX
25%
Poorly correlated
+5.85%
More
A.I. Advisor
published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Industry
Pharmaceuticals Major
Address
Kiryat Hadassah
Phone
+972 25327151
Employees
22
Web
https://www.enterabio.com
Entera Bio (ENTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com